Bio-IT World - Indispensable Technologies Driving Drug Discovery, Development, and Clinical Trials.

Bio-IT World, the flagship publication of Cambridge Healthtech Institute (CHI), is the leading source of news on technology and strategic innovation in drug discovery, development, and clinical trials. Bio-IT World explores the tools and results of predictive biology as the industry adapts to the new world of personalized medicine.

In 2008, the magazine will focus on key technologies that are shaping the industry--high throughput sequencing, pathway analysis, adaptive clinical trials, the Semantic web, biomarkers, in silico screening, high performance computing, and much more. Expert views from an outstanding group of columnists on the world of translational medicine, science and the web, IT and informatics solutions will also be showcased. (Tradepub.com)

Bio-IT World covers the use of information technology, informatics, data-generating life sciences equipment and business services to advance research and development in life sciences organizations, including biotechnology, pharmaceutical, academia, healthcare and government.

Bio-IT World’s award-winning editorial provides an end-to-end prospective on the indispensable technologies which drive the life science community - in drug research, development, clinical trials, and compliance. (biotechmedia.com)

Publisher: Cambridge Healthtech Media Group, division of Cambridge Healthtech Institute (CHI)

Click Here, Get Free Subscription to Bio-IT World

Qualify for Your Free Subscription!

Geographic Eligibility: USA (Print or Digital Versions), Canada & Select International (Digital Version Only)

Your free subscription includes:

• News and interviews on bioinformatics, data centers, IT workflows, clinical trials, electronic data capture ...
• Feature Articles on discovery informatics, LIMS, microarray analysis platforms, high performance computing...
• Regular columnists: Science and the Web, Nothing Ventured, The Russell Report, Insights & Outlooks...
• Special Reports on major topics including EDC, predictive modeling, translational medicine, toxicity and safety, genome analysis, discovery informatics, adaptive clinical trials...
• Full Access on Bio-ITWorld.com to daily news, archives, exclusive interviews, video webcasts, commentaries, resource centers, white papers, events...
• Free e-newsletters on e-clinical research, systems biology, digital healthcare & productivity, biopharmaceutical business insights, IT & infromatic trends ...

... and more! Apply for your FREE SUBSCRIPTION today!

Visit Bio-IT World Website

Bio-IT World is focused on the convergence of information technology and the life sciences. Written for senior IT/scientific management, coverage spans life science and research organizations, including pharmaceuticals, biotechnology, drug discovery/ development, genomics and proteomics. (Magazines.com)

Top Headlines:
Amgen Looks to Biomarkers to Boost Drug Development
Aug 08 | Xconomy | Amgen had an epiphany of sorts a little more than four years ago. The world’s largest biotech company decided clinical trials had become too much of a crapshoot, and it needed to shake up its way of developing new drugs.

Harvard Team Makes 10 Disease-Bearing Stem Cell Lines
Aug 08 | Bloomberg | Harvard University scientists have made lines of stem cells, able to turn into any other cell in the body, from bits of skin or blood of 10 patients with genetic diseases including muscular dystrophy and juvenile diabetes.

Covance Buys Eli Lilly Facility in 10-Year Deal
Aug 08 | Forbes/AP |Drug-development services company Covance Inc. will buy an Indiana research center from Eli Lilly and Co. and enter a 10-year service deal with the drug maker worth $1.6 billion.

Comments (0)

Name

Email

Comment

smaller | bigger

Add Comment